Are peptides safe? An evidence-first guide.
Peptides are not one thing. A few are approved prescription drugs with decades of trial data; most are unapproved compounds whose human evidence ranges from thin to non-existent. This site takes them one at a time and reports what the record says: the human studies, the known risks, and the legal status in Canada and the United States.
Every peptide, by verdict
The verdict describes regulatory and evidential standing, not a recommendation.How we rate →
Regulatory status as of October 2026. Verdicts track the regulatory record, which changes without notice; each entry carries its own date.
Approved Approved by a regulator for a human indication
Approved by the FDA and/or Health Canada for at least one human indication. Safety has been characterised in clinical trials and is described on an official product label. Approved does not mean safe for everyone, or safe outside the indication it was approved for.
Investigational Unapproved, with substantial published trial data
Unapproved, with substantial published trial data. No regulator has authorised it for any human use, so legally it sits exactly where an unapproved compound sits — but unlike most unapproved peptides it has been through registered human trials that have reported, so there is a real body of evidence on what it does and what goes wrong. What is missing is the long-term and post-approval record: the trials that surface uncommon or delayed harms have not finished, and nothing has been reviewed by a regulator.
Unapproved Not approved; evidence thin or absent
Not approved for human use by the FDA or Health Canada. The human evidence is limited, animal-only, or absent. Material sold outside regulated channels also has no verified identity, purity or stability, which is a separate risk from the molecule itself.
Avoid Documented harm or regulator warning
Carries a documented serious safety signal, an explicit regulator warning, or published reports of serious harm. This is the one verdict on the scale that is a recommendation, and it is only used when a named authority has said so in writing.
No peptide matches that search. Browse all 16 entries →
How we rate
- Approved — Approved by a regulator for a human indication.
- Investigational, not approved — Unapproved, with substantial published trial data.
- Unapproved — Not approved; evidence thin or absent.
- Avoid — Documented harm or regulator warning.
Separately from the verdict, every entry carries an evidence level — strong, limited, animal-only or none — describing how well the claimed effects have been tested in humans. The two are independent: a drug can be approved for one indication and have no evidence at all for the use it is promoted for online.
Are peptides safe?
“Peptide” describes size, not function: any short chain of amino acids. The category includes insulin, in clinical use for a century, and compounds sold online that have never been given to a human in a registered trial. So the question as asked has no answer. The answerable version is: which peptide, for whom, and from where?
Three groups behave very differently.
Approved drugs. A small number of peptides are approved by the FDA and Health Canada for specific indications. Their risks are known in the ordinary pharmaceutical sense — measured in clinical trials, listed on an official label, and tracked after approval. They are prescription-only, and their safety record applies to the population and the indication they were studied in, not to everyone who wants them.
Investigational peptides. Some are in registered human trials but approved nowhere. There is genuine human data, and it is incomplete by definition: the long and large trials that surface uncommon or delayed harms have not finished.
Unapproved peptides. Most compounds marketed as “peptides” sit here, and they carry two separate risks. The first is the molecule — effects and harms never characterised in people. The second is the product itself: material outside the regulated supply chain has no verified identity, purity, sterility or stability, so what is in the container is unknown even where the molecule is well understood. In the United States the FDA regulates compounded preparations separately from approved drugs and restricts which bulk substances may be used in them; in Canada, Health Canada publishes advisories about unauthorised health products.
Two things are worth holding onto. “No reported harms” usually means nobody has looked, not that nothing happens — absence of evidence is not evidence of safety. And animal results, which is the entire evidence base for several popular peptides, routinely fail to reproduce in humans.
Every entry here states its evidence level and its legal status in both countries, so you can see which of the three groups a peptide is actually in before you read anything else about it.
Frequently asked questions
Are peptides legal in Canada and the United States?
It depends entirely on the peptide. A few are approved prescription drugs in both countries and are legal to use with a prescription. Most of the peptides discussed online are not authorised for human use by either regulator, which means they cannot be legally sold for that purpose — and are instead marketed as research chemicals to sidestep that. Each entry on this site states the status in both countries separately, because they often differ.
Does "research use only" mean a peptide is safe?
No. It is a regulatory label, not a safety finding. It means the material has not been authorised for use in people, so no regulator has assessed its safety, and the manufacturer is making no claim about identity, purity or sterility for human use. The phrase describes an absence of review rather than the result of one.
Is a compounded peptide the same as an approved drug?
No. An approved drug has been reviewed by a regulator, is made under inspected manufacturing rules, and carries an official label listing its risks. A compounded preparation is made by a pharmacy for a particular patient and is not individually reviewed or approved. In the United States the FDA restricts which bulk substances may be compounded at all, and several popular peptides are not permitted.
What does an evidence level of "animal-only" mean?
That the claimed effect has been observed in animals or in cell culture, and never tested in a completed human trial. It is a real finding about rodents, not a weak finding about people. Results in animals routinely fail to reproduce in humans, so an animal-only evidence level supports no conclusion about what a peptide does in a person.
Sources for this page
- FDAHuman Drug CompoundingHow the FDA regulates compounded preparations, and which bulk substances may be used in them.
- Health CanadaDrugs and health productsHealth Canada’s authorisation regime, the Drug Product Database and its advisories on unauthorised products.
- ClinicalTrials.govClinicalTrials.govThe registry we use to check whether a peptide has ever been tested in a registered human trial.
- PubMedPubMedThe literature index behind every evidence level on this site.